AlphaTON Capital Corp. (ATON) Research

AlphaTON Capital Corp. has undergone a strategic transformation, rebranding from its previous identity as Portage Biotech Inc. While formerly engaged as a clinical-stage immuno-oncology firm, the company is now pivoting its operations towards a digital asset treasury model. This new focus primarily involves the acquisition and staking of Toncoin (TON). AlphaTON's ambition is to make significant investments in TON tokens, with the goal of building a long-term Toncoin treasury valued at approximately US$100 million.

Market snapshot

Symbol
ATON
Price
$0.25
Day change
-2.81%
Market cap
$5.9M
P/E ratio
-0.03x
52-week range
0.176-13.8
Sector
Financial Services
Industry
Asset Management
Next earnings
in 1 month
Analyst price target
$4.88

Recent news

  • Anthony Scaramucci-Linked AlphaTON (ATON) Rebrands As Alpha Compute In 'Hard To Do' AI Pivot, CEO Terms Nvidia GPUs As 'Core' Balance Sheet Assets

    AlphaTON Capital Corp. (NASDAQ: ATON) rebranded as Alpha Compute Corp. on Monday, with shares set to begin trading under the new ticker "ALP," m

Peer companies

  • AMTD IDEA Group (AMTD)
  • Aurelion Inc. (AURE)
  • Tianci International, Inc. (CIIT)
  • Fold Holdings Inc (FLD)
  • Garden Stage Limited Ordinary Shares (GSIW)
  • CSLM Digital Asset Acquisition Corp III Class A Ordinary Shares (KOYN)
  • LightWave Acquisition Corp. (LWAC)
  • Magic Empire Global Limited (MEGL)

Open AlphaTON Capital Corp. (ATON) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.